arrow
A

Adrian Levine

hospital for sick children
H指数:11
被引数:827

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma

错配修复缺陷型神经胶质瘤的高突变形状肿瘤发生和免疫治疗反应的模式

2025-12-220
PRE
Unveiling MYH2-related myopathy: Histological-genetic insights from a case series and systematic review

揭示MYH2相关肌病:来自病例系列和系统综述的组织学-遗传学见解

2025-11-180
OA
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma

整合的播散性儿童低级别胶质瘤临床与分子全景

2025-10-210
PRE
Clinical utility of targeted RNA sequencing in cancer molecular diagnostics

靶向RNA测序在癌症分子诊断中的临床应用

2025-07-170
PRE
A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis

基于人群的胶质瘤分子景观分析揭示了青少年和年轻成人胶质瘤发生的见解

2025-05-070
PRE
TRANSLATING COMBINED PD1 AND LAG3 INHIBITION FROM PRECLINICAL MODELS TO PATIENTS WITH REFRACTORY, DNA REPLICATION REPAIR DEFICIENT (RRD) GLIOBLASTOMA: AN IRRDC STUDY
2024-11-110
PRE
TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE CHECKPOINT INHIBITION: AN IRRDC REPORT
2024-11-110
PRE
Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma

组蛋白去乙酰化酶和碳酸酐酶9抑制剂的联合治疗在实验性弥漫性内生性脑桥胶质瘤中显示出治疗潜力

2024-09-240
PRE
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment

小儿脑肿瘤的免疫肿瘤学分析揭示了肿瘤免疫微环境的主要临床意义

2024-07-102
OAAI
POOR RESPONSE TO MEKI RE-INITIATION IN PEDIATRIC LOW-GRADE GLIOMA AFTER TREATMENT DISCONTINUATION. A PLGG TASKFORCE STUDY
2024-06-180
OAAI
THE LANDSCAPE OF GLIOMAS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS REVEALS INSIGHTS ON GLIOMAGENESIS: A CANADIAN ADOLESCENTS AND YOUNG ADULTS NEURO-ONCOLOGY NETWORK (CANON) STUDY
2024-06-180
OAAI
COMBINED PD1 AND LAG3 INHIBITION IN PRECLINICAL MODELS AND PATIENTS WITH DNA REPLICATION REPAIR DEFICIENT GLIOBLASTOMA (RRD-GBM): AN IRRDC STUDY
2024-06-180
OAAI
TRANS-SPECIES STUDY OF IDH-MUTANT REPLICATION-REPAIR DEFICIENT HIGH-GRADE GLIOMAS (RRD-HGG) AND RESPONSE TO COMBINED TARGETED AND IMMUNOTHERAPY: AN IRRDC STUDY
2024-06-180
OAAI
INTEGRATED CLINICAL AND MOLECULAR CHARACTERIZATION OF 200 DISSEMINATED PEDIATRIC LOW-GRADE GLIOMAS
2024-06-180
OAAI
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium

联合免疫疗法可改善Anti-PD-1单一疗法失败的复制修复缺陷 (RRD) 高级别神经胶质瘤的结果: 来自国际RRD联盟的报告

2023-10-1212
OAAI